Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Akers Biosciences

(NASDAQ: AKER)
Add to Portfolio
-0.02 (-0.58%)
as of Feb 21, 2020

Last 3.42
Change -0.02 (-0.58%)
Open 3.44
Prev. Close 3.44
Today's Range
3.31
3.50
52wk Range
2.67
30.24
Volume 139,255
Avg Volume 177,823
Sector SIC-2835 In Vitro & In Vivo Diagnostic Substances

Perfomance Comparison

Name Today 3-Month 1-Year
AKER -0.58% +16.50% -86.41%
DJIA -0.78% +3.88% +12.15%
S&P 500 -1.05% +6.43% +20.28%

Key Statistics

Annual EPS -12.95
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 1,740
Weighted Alpha -64.76
Standard Deviation -0.09
Profit Margin N/A
Beta -0.95

Growth Rates

YTD +7.03%
1-Year -85.52%
3-Year -98.57%
5-Year -99.53%

Opinion

Sell Hold Buy

Recent Headlines

Aker BP ASA: Fourth Quarter 2019 Results and Capital

PRNW - Tue Feb 11, 01:19AM EST
TRONDHEIM, Norway , Feb. 11, 2020 /PRNewswire/ -- Fourth quarter 2019 marked the end of a year of strong progress and value creation for Aker BP. For the first time, the company's quarterly total income exceeded one bill(full story)
AKER: 3.42 (-0.02), AKAAF: 54.0000 (unch)

Akers Biosciences, Inc. Provides Notice of Proposed

GlobeNewswire via COMTEX - Fri Jan 17, 05:00PM EST
Akers Biosciences, Inc. (the "Company") (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it reached a settlement agreement to settle two shareholder derivative actions: Watts v. Gormally, (full story)
AKER: 3.42 (-0.02)

Akers BioSciences Regains Compliance with Nasdaq

GlobeNewswire via COMTEX - Wed Dec 11, 09:30AM EST
Akers Biosciences, Inc. (the "Company") (NASDAQ: AKER), a developer of rapid health information technologies, announced today that on December 10, 2019, it received notice from the Hearings Advisor of the Nasdaq Office of General (full story)
AKER: 3.42 (-0.02)

Akers Biosciences to Present at the Investor Summit on

ACCESSWIRE via COMTEX - Tue Dec 10, 11:30AM EST
THOROFARE, NJ / ACCESSWIRE / December 10, 2019 / Akers Biosciences, Inc. (NASDAQ:AKER), will be presenting at this year's Investor Summit on December 17th in Philadelphia.(full story)
AKER: 3.42 (-0.02)

Akers BioSciences, Inc. Announces Closing of

GlobeNewswire via COMTEX - Mon Dec 09, 11:40AM EST
Akers Biosciences, Inc. (the "Company" or "we") (NASDAQ: AKER), a developer of rapid health information technologies, today announced the closing of its previously announced public offering of 613,500 common units at a public offe(full story)
AKER: 3.42 (-0.02)